The Functional Organisation And Signals Of Motion Sensitive Neurons In The Middle-temporal Area Of Visual Cortex
Funder
National Health and Medical Research Council
Funding Amount
$405,337.00
Summary
Some nerve cells in the cerebral cortex are very sensitive to visual motion. These neurons direct eye movements and provide motion perception, but the "neuronal code" they carry is poorly understood. We will address this basic question in experimental studies of the primate visual system. This project will help us understand visual performance; poor motion vision is an early indicator of many neurological disorders and this knowledge can help develop methods for their detection and diagnosis.
Effects Of Electromagnetic Radiation On Visual Processing
Funder
National Health and Medical Research Council
Funding Amount
$299,564.00
Summary
We are increasingly surrounded by devices such as mobile phones and wireless networks. The effect of this electromagnetic radiation on human physiology is still largely unknown. Recent research has shown increases in "alpha-wave" electrical activity in the human brain after exposure to mobile phone radiation, but no effect has yet been shown on human mental processes. We plan to explore the effects of the electromagnetic environment on human visual processing, using sensitive techniques that wil ....We are increasingly surrounded by devices such as mobile phones and wireless networks. The effect of this electromagnetic radiation on human physiology is still largely unknown. Recent research has shown increases in "alpha-wave" electrical activity in the human brain after exposure to mobile phone radiation, but no effect has yet been shown on human mental processes. We plan to explore the effects of the electromagnetic environment on human visual processing, using sensitive techniques that will help reveal the underlying brain processes.Read moreRead less
Characterising The Changes In Regulation Of Visual Contrast Sensitivity In Glaucoma.
Funder
National Health and Medical Research Council
Funding Amount
$337,600.00
Summary
Glaucoma is the second leading cause of blindness in developed nations. A recent study estimated the number of Australian's that will need regular visual examination in 2030 either because they have glaucoma or glaucomatous risk factors to be at least 800,000. As the ultimate aim of glaucoma treatment is to maintain vision, visual functional assessment is of paramount importance to glaucoma management . The current standard measure for the assessment of visual loss due to glaucoma is visual fiel ....Glaucoma is the second leading cause of blindness in developed nations. A recent study estimated the number of Australian's that will need regular visual examination in 2030 either because they have glaucoma or glaucomatous risk factors to be at least 800,000. As the ultimate aim of glaucoma treatment is to maintain vision, visual functional assessment is of paramount importance to glaucoma management . The current standard measure for the assessment of visual loss due to glaucoma is visual field testing. Regrettably, substantial damage to retinal ganglion cells (the primary neurons affected by glaucoma) is often present prior to the discovery of visual field loss using standard measures. Indeed studies have demonstrated that even 30-50% retinal ganglion cell loss may only manifest as a mild visual field deficit using current standard testing. This project will use novel techniques for exploring sight impairment in glaucoma, enabling a better understanding of the underlying neural damage. Our pilot work demonstrates that these methods can detect loss of sight in areas diagnosed as normal using standard visual field testing. The study will provide new technologies for the assessment of early vision loss due to glaucoma that may enable the detection of malfunction of retinal ganglion cells prior to their death. Such measures of neural malfunction are essential to establishing the efficacy of new pharmacological therapies (known as neuroprotective agents) for glaucoma aimed at keeping retinal ganglion cells alive and functioning. This project also has the potential to identify visual measures that have better capability for monitoring the progression of vision loss due to glaucoma. Early detection of glaucoma and its progression is essential so that treatment can be initiated or altered, slowing the progression of vision loss and its toll on both the individual and the community.Read moreRead less
Is Insulin Sensitivity In Children And Their Mothers Programmed By Maternal Blood Glucose?
Funder
National Health and Medical Research Council
Funding Amount
$169,630.00
Summary
Glucose intolerance in pregnancy is associated with the birth of large-for-dates and macrosomic (>4000g) babies. The risk of type 2 diabetes is greater in babies who are small or large at birth compared to those with normal birth weight. This study will determine if treatment of mothers with glucose intolerance in pregnancy (which is intermediate between normal glucose tolerance and diabetes) alters the regulation of glucose tolerance in their children. The mothers were randomised to receive ....Glucose intolerance in pregnancy is associated with the birth of large-for-dates and macrosomic (>4000g) babies. The risk of type 2 diabetes is greater in babies who are small or large at birth compared to those with normal birth weight. This study will determine if treatment of mothers with glucose intolerance in pregnancy (which is intermediate between normal glucose tolerance and diabetes) alters the regulation of glucose tolerance in their children. The mothers were randomised to receive normal antenatal care or to have their blood sugar measured and controlled by diet and insulin as for diabetics. We will measure the insulin sensitivity of the children to a glucose load. We will also measure blood pressure and lipids in these children. Treatment of the mother during pregnancy may alter the deposition of fat in the fetus the effect of which will continue into childhood. Thus the offspring of treated mothers may remain thinner throughout childhood. Each pregnancy increases a woman's chance of developing type 2 diabetes in later life. This risk is further increased by abnormal glucose tolerance during pregnancy. This study will test the long-term benefits of treatment during pregnancy of women with impaired glucose tolerance on the subsequent regulation of glucose tolerance. We shall invite women who took part in the Australian Carbohydrate Study in Pregnancy (ACHOIS) to return and have an intravenous glucose tolerance test. Insulin sensitivity and glucose tolerance will be determined and related to treatment of the impaired glucose tolerance in pregnancy. This study will be the first follow-up of a large randomised trial of treatments of impaired glucose tolerance in pregnancy. The potential long-term benefits are strategies to reduce the future chance of developing risk factors for type 2 diabetes, obesity and abnormal blood lipids in childhood and adult life. The study will establish the benefits or otherwise of tight control of blood glucose in pregnancy.Read moreRead less